CERC is pleased to announce the upcoming MARVEL TAVI Investigator Meeting, taking place on November 23, 2026, during PCR London Valves in London.
Can TAVI expand treatment options for patients with pure aortic regurgitation?
The meeting will bring together investigators and study teams to discuss the MARVEL TAVI study and explore how the Myval THV series could broaden transcatheter treatment possibilities for this patient population.
The meeting will be led by Dr. Ignacio J. Amat-Santos, Principal Investigator at Hospital Clínico Universitario de Valladolid, Spain.
Meeting details
- Date: Monday, November 23, 2026
- Time: 3:00–4:00 PM (London time)
- Venue: Platinum Suite, Level 3, ExCeL Exhibition Centre, Royal Victoria Dock, London, UK
- RSVP: marveltavi@cerc-europe.org
The meeting is organized with the support of Meril and CERC serving as the Contract Research Organization (CRO).
Learn more about the study: https://www.cerc-europe.org/trials/structural-heart-disease/marvel-tavi
We look forward to welcoming investigators and study teams in London.
